Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi

Authors


Ann Gils, Laboratory for Pharmaceutical Biology, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Campus Gasthuisberg, O&N2, PB 824, Herestraat 49, B-3000 Leuven, Belgium.
Tel.: +32 16 32 34 36 ; fax: +32 16 32 34 60.
E-mail: ann.gils@pharm.kuleuven.be

No abstract is available for this article.

Ancillary